Celexa

This page shows the latest Celexa news and features for those working in and with pharma, biotech and healthcare.

Lundbeck and Otsuka start phase III for Rexulti in bipolar

protection for Abilify and former blockbuster antidepressant Lexapro/Celexa (escitalopram).

Lundbeck challenge to EC pay-for-delay ruling fails

Court upholds 94m fine for paying off firms to delay launch of Celexa generics. ... Lundbeck insists it did not go beyond the protection already offered by its patent rights on Celexa.
Lundbeck and Otsuka's Rexulti set for August launch in US

which it hopes will restore growth after the loss of patent protection on US blockbuster antidepressant Lexapro/Celexa (escitalopram).
Lundbeck CEO resigns after rule breach

Compounding this has been a legal battle with the European Commission, which ruled that Lundbeck collaborated with several other companies to delay the entry of generic competition for Celexa/ Cipramil (citalopram).
EC fines J&J and Novartis in pay-for-delay case

A case involving AstraZeneca and Nycomed was dropped last year. Earlier this year Danish pharma company Lundbeck was fined almost 94m for a pay-for-delay deal involving its antidepressant
Lundbeck presses on with cost-saving programme

its big-selling antidepressant Celexa/ Cipramil (citalopram).

More from news
Approximately 1 fully matching, plus 12 partially matching documents found.

Add my company

M3 was founded in 2000 with the goal of changing the world of medicine through making full use of the...

Working together against COVID-19: Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19: Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?: Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....